Welcome to Arctom, sign up to enjoy up to
20% OFF
+1 800-931-7508
[email protected]
Search in Small Molecules
Search in Biologics
Structure Search
Sign in
Register
Cart - 0 item(s)
$0.00
Your shopping cart is empty!
Building Blocks
Alcohols and Derivatives
Amines and Anilines
Amino Acids and Derivatives
Boronic Acids and Esters
Carbonyl Compounds
Halides
Heterocycles
Nitrogen Compounds
Phosphorus Compounds
Sulfur Compounds
Functional Material
Oxygen Compounds
Chemistry
Inhibitors
Natural Products
Antibodies
ADCs
Toxins
Linkers
Payloads with linkers
Miscellaneous
Material Science
Others
Catalysts
Rare Earth Metal Compounds
Transition Metal Compounds
Other
Chiral Compound
Chiral Reagents/Auxiliary
Lithium Reagent
Grignard Reagents
Silylating Reagents
Organosilicon Compounds
Inorganic Salts
Inorganic Compounds
Coupling Reagent
Oxidant
Reductant
Sugars
Rock
Tin Compounds
Our clients include world's top universities and pharmaceutical organizations
Valneva SE
Thursday, March 21, 2024
Valneva to Present on its Chikungunya Vaccine IXCHIQ®, Participate in Multiple Events at the 24th World Vaccine Congress in Washington D.C.
Ono Pharmaceutical
Thursday, March 21, 2024
Bristol Myers Squibb Announces CheckMate -9DW Trial Evaluating Opdivo (nivolumab) Plus Yervoy (ipilimumab) Meets Primary Endpoint of Overall Survival for the First-Line Treatment of Advanced Hepatocellular Carcinoma
Precision BioSciences
Wednesday, March 20, 2024
Precision BioSciences to Report Fourth Quarter and Fiscal Year 2023 Results on March 27, 2024
Viking Therapeutics
Wednesday, March 20, 2024
Viking Therapeutics Reports Fourth Quarter and Year-End 2023 Financial Results and Provides Corporate Update
AACR Annual Meeting 2024
Friday, April 5, 2024
San Diego, California
2024 AAN Annual Meeting
Saturday, April 13, 2024
Denver, CO
2024 USASP Annual Scientific Meeting
Sunday, April 14, 2024
Seattle, Washington
New England Journal of Medicine
Wednesday, March 20, 2024
Intrathecal Gene Therapy for Giant Axonal Neuropathy
New England Journal of Medicine
Wednesday, March 20, 2024
Anti–Interleukin-23 Autoantibodies in Adult-Onset Immunodeficiency
New England Journal of Medicine
Wednesday, March 20, 2024
Ribociclib plus Endocrine Therapy in Early Breast Cancer
New England Journal of Medicine
Wednesday, March 20, 2024
Risk of Autism after Prenatal Topiramate, Valproate, or Lamotrigine Exposure
211
211
CRISPR CAS9 Step by step explanation.
105
105
CRISPR Technology: Role of CRISPR gene editing in Cancer Research Landscape #crispr #biotech
28
28
Immune-related adverse events in breast cancer patients taking ICIs
73
73
Use of checkpoint inhibitors in breast cancer treatment
Chugai Pharmaceutical
Wednesday, March 20, 2024
Chugai Selected as a “Nadeshiko Brand”
Chugai Pharmaceutical
Wednesday, March 20, 2024
Results of Phase III Study of Enspryng in Patients with Generalized Myasthenia Gravis
Bayer
Wednesday, March 20, 2024
Bayer and Thermo Fisher Scientific collaborate to increase patient access to precision cancer medicines
Bayer
Wednesday, March 20, 2024
Bayer Pharmaceuticals streamlines Leadership Team for next phase of growth
45th SIMD Annual Meeting
Sunday, April 14, 2024
Charlotte, NC
22nd BTOG Annual Conference 2024
Wednesday, April 17, 2024
Belfast, UK
2024 PENS National Conference
Wednesday, April 17, 2024
St. Louis, MO
Lancet
Tuesday, March 19, 2024
Pembrolizumab or placebo with chemoradiotherapy followed by pembrolizumab or placebo for newly diagnosed, high-risk, locally advanced cervical cancer (ENGOT-cx11/GOG-3047/KEYNOTE-A18): a randomised, double-blind, phase 3 clinical trial
Lancet
Tuesday, March 19, 2024
Global fertility in 204 countries and territories, 1950–2021, with forecasts to 2100: a comprehensive demographic analysis for the Global Burden of Disease Study 2021
Nature Medicine
Monday, March 18, 2024
Neoadjuvant nivolumab or nivolumab plus LAG-3 inhibitor relatlimab in resectable esophageal/gastroesophageal junction cancer: a phase Ib trial and ctDNA analyses
Nature Medicine
Monday, March 18, 2024
Heterogeneity and predictors of the effects of AI assistance on radiologists
24
24
CRISPR-Cas9: The Future of Genetic Engineering
274
274
Real-World CAR-T Data Update
125
125
CRISPR & HIV
191
191
Allergen immunotherapy Vaccine dose कितना दिन तक लेना चाहिए? Immunotherapy for Allergy free Life
Viking Therapeutics
Wednesday, March 20, 2024
Viking Therapeutics Announces Positive Top-Line Results from Phase 2 VENTURE Trial of Dual GLP-1/GIP Receptor Agonist VK2735 in Patients with Obesity
Tonix Pharmaceuticals
Wednesday, March 20, 2024
Tonix Pharmaceuticals Announces Selection of Two Contract Manufacturing Organizations for the Launch and Commercial Manufacture of Tonmya™ for the Management of Fibromyalgia
BridgeBio Pharma
Wednesday, March 20, 2024
BridgeBio Pharma Reports Inducement Grants under Nasdaq Listing Rule 5635(c)(4)
Altimmune
Wednesday, March 20, 2024
Altimmune to Report Fourth Quarter and Full Year 2023 Financial Results and Provide Business Update on March 27, 2024
ECCMID 2024
Saturday, April 27, 2024
Barcelona, Spain
10th Annual ELITE PED-GI Congress 2024
Thursday, May 2, 2024
Abu Dhabi, United Arab Emirates
2024 PES Annual Meeting
Thursday, May 2, 2024
Chicago, IL
Nature
Monday, March 18, 2024
Long-term continuous ammonia electrosynthesis
Nature Medicine
Monday, March 18, 2024
A visual-language foundation model for computational pathology
Nature Medicine
Monday, March 18, 2024
Towards a general-purpose foundation model for computational pathology
Nature
Sunday, March 17, 2024
Structural insights into vesicular monoamine storage and drug interactions
131
131
The world’s first vaccine to prevent lung cancer | Tech & Science Daily podcast
118
118
US gov. sues Apple, lung cancer vaccine, microplastics at Roman dig | Tech & Science Daily podcast
275
275
CRISPR could disable and cure HIV, suggests promising lab experiment
214
214
Why breast cancer is on the rise
Amicus Therapeutics
Wednesday, March 20, 2024
Amicus Therapeutics Issues 2024 Environmental, Social, and Governance (ESG) Report
Valneva SE
Wednesday, March 20, 2024
Valneva Reports Full Year 2023 Results and Provides Business Updates and Outlook
Aquestive Therapeutics
Wednesday, March 20, 2024
Aquestive Therapeutics Announces Pricing of $75 Million Underwritten Public Offering of Common Stock
MediciNova
Wednesday, March 20, 2024
MediciNova Announces Two Abstracts regarding MN-001 (tipelukast) and MN-002 Accepted for Presentation at the 92nd EAS 2024 Congress, the Annual Meeting of the European Atherosclerosis Society
2024 AANS Annual Scientific Meeting
Friday, May 3, 2024
Chicago, IL
ATA Nexus 2024
Sunday, May 5, 2024
Phoenix, AZ
ACOOG 91st Annual Conference
Sunday, May 5, 2024
Bonita Springs, Florida
Science
Thursday, March 14, 2024
Diversity begets stability: Sublinear growth and competitive coexistence across ecosystems
Science
Thursday, March 14, 2024
Cryptic diversity of cellulose-degrading gut bacteria in industrialized humans
Science
Thursday, March 14, 2024
Continuous evolution of compact protein degradation tags regulated by selective molecular glues
Science
Thursday, March 14, 2024
Oral administration of obeldesivir protects nonhuman primates against
78
78
Prehabilitation and rehabilitation for breast cancer surgery
45
45
The evolution of immunotherapy in brain tumor treatment
101
101
CRISPR-Cas9: Hope in the Fight Against HIV/AIDS
146857
146857
The First CRISPR Gene Therapy Is Here
Not More
Show More
loading...